Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'health/india039s-first-japanese-encephalitis-vaccine-launched-17117/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/health/india039s-first-japanese-encephalitis-vaccine-launched-17117/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'health/india039s-first-japanese-encephalitis-vaccine-launched-17117/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/health/india039s-first-japanese-encephalitis-vaccine-launched-17117/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-trace').style.display = (document.getElementById('cakeErr67ecc790e0a91-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc790e0a91-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-code').style.display = (document.getElementById('cakeErr67ecc790e0a91-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-context').style.display = (document.getElementById('cakeErr67ecc790e0a91-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc790e0a91-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ecc790e0a91-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16989,
		&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 29,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17117,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16989,
	&#039;metaTitle&#039; =&gt; &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Encephalitis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16989,
	&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 29,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17117,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16989
$metaTitle = &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;
$metaKeywords = &#039;Encephalitis,Health&#039;
$metaDesc = &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>health/india039s-first-japanese-encephalitis-vaccine-launched-17117.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Health | India&#039;s first Japanese encephalitis vaccine launched | Im4change.org</title>
    <meta name="description" content="
-PTI

Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India&#039;s first Japanese encephalitis vaccine launched</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-PTI<br /><br />Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br /><br />The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br /><br />&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br /><br />The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br /><br />Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br /><br />BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br /><br />Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br /><br />JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br /><br />JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx" title="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s<br />-first-Japanese-encephalitis-vaccine-launched/Article1-929<br />430.aspx</a> </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-trace').style.display = (document.getElementById('cakeErr67ecc790e0a91-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc790e0a91-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-code').style.display = (document.getElementById('cakeErr67ecc790e0a91-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-context').style.display = (document.getElementById('cakeErr67ecc790e0a91-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc790e0a91-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ecc790e0a91-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16989,
		&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 29,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17117,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16989,
	&#039;metaTitle&#039; =&gt; &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Encephalitis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16989,
	&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 29,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17117,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16989
$metaTitle = &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;
$metaKeywords = &#039;Encephalitis,Health&#039;
$metaDesc = &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>health/india039s-first-japanese-encephalitis-vaccine-launched-17117.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Health | India&#039;s first Japanese encephalitis vaccine launched | Im4change.org</title>
    <meta name="description" content="
-PTI

Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India&#039;s first Japanese encephalitis vaccine launched</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-PTI<br /><br />Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br /><br />The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br /><br />&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br /><br />The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br /><br />Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br /><br />BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br /><br />Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br /><br />JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br /><br />JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx" title="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s<br />-first-Japanese-encephalitis-vaccine-launched/Article1-929<br />430.aspx</a> </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-trace').style.display = (document.getElementById('cakeErr67ecc790e0a91-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ecc790e0a91-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-code').style.display = (document.getElementById('cakeErr67ecc790e0a91-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ecc790e0a91-context').style.display = (document.getElementById('cakeErr67ecc790e0a91-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ecc790e0a91-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ecc790e0a91-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 16989,
		&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 29,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 17117,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 16989,
	&#039;metaTitle&#039; =&gt; &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Encephalitis,Health&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 16989,
	&#039;title&#039; =&gt; &#039;India&amp;#039;s first Japanese encephalitis vaccine launched&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-PTI&lt;br /&gt;
&lt;br /&gt;
Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;
&lt;br /&gt;
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;
&lt;br /&gt;
&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;
&lt;br /&gt;
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;
&lt;br /&gt;
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;
&lt;br /&gt;
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;
&lt;br /&gt;
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;
&lt;br /&gt;
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;
&lt;br /&gt;
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&amp;nbsp;
&lt;/div&gt;
&lt;div align=&quot;justify&quot;&gt;
&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 29,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india039s-first-japanese-encephalitis-vaccine-launched-17117&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 17117,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 16989
$metaTitle = &#039;Health | India&amp;#039;s first Japanese encephalitis vaccine launched&#039;
$metaKeywords = &#039;Encephalitis,Health&#039;
$metaDesc = &#039;
-PTI

Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-PTI&lt;br /&gt;&lt;br /&gt;Pharma firm Biological E Limited (BEL) today launched the country&#039;s first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.&lt;br /&gt;&lt;br /&gt;The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.&lt;br /&gt;&lt;br /&gt;&amp;quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&amp;quot; she said.&lt;br /&gt;&lt;br /&gt;The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.&lt;br /&gt;&lt;br /&gt;Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.&lt;br /&gt;&lt;br /&gt;BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.&lt;br /&gt;&lt;br /&gt;Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).&lt;br /&gt;&lt;br /&gt;JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.&lt;br /&gt;&lt;br /&gt;JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&amp;nbsp;&lt;/div&gt;&lt;div align=&quot;justify&quot;&gt;&lt;em&gt;The Hindustan Times, 13 September, 2012, &lt;a href=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot; title=&quot;http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx&quot;&gt;http://www.hindustantimes.com/India-news/Hyderabad/India-s&lt;br /&gt;-first-Japanese-encephalitis-vaccine-launched/Article1-929&lt;br /&gt;430.aspx&lt;/a&gt; &lt;/em&gt;&lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>health/india039s-first-japanese-encephalitis-vaccine-launched-17117.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>Health | India&#039;s first Japanese encephalitis vaccine launched | Im4change.org</title>
    <meta name="description" content="
-PTI

Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India&#039;s first Japanese encephalitis vaccine launched</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-PTI<br /><br />Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br /><br />The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br /><br />&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br /><br />The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br /><br />Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br /><br />BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br /><br />Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br /><br />JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br /><br />JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx" title="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s<br />-first-Japanese-encephalitis-vaccine-launched/Article1-929<br />430.aspx</a> </em><br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 16989,
		'title' => 'India's first Japanese encephalitis vaccine launched',
		'subheading' => '',
		'description' => '<div align="justify">
-PTI<br />
<br />
Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br />
<br />
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br />
<br />
&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br />
<br />
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br />
<br />
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br />
<br />
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br />
<br />
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br />
<br />
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br />
<br />
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx</a> </em><br />
</div>',
		'credit_writer' => 'The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 29,
		'tag_keyword' => '',
		'seo_url' => 'india039s-first-japanese-encephalitis-vaccine-launched-17117',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 17117,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 16989,
	'metaTitle' => 'Health | India&#039;s first Japanese encephalitis vaccine launched',
	'metaKeywords' => 'Encephalitis,Health',
	'metaDesc' => '
-PTI

Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...',
	'disp' => '<div align="justify">-PTI<br /><br />Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br /><br />The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br /><br />&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br /><br />The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br /><br />Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br /><br />BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br /><br />Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br /><br />JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br /><br />JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx" title="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s<br />-first-Japanese-encephalitis-vaccine-launched/Article1-929<br />430.aspx</a> </em><br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 16989,
	'title' => 'India&#039;s first Japanese encephalitis vaccine launched',
	'subheading' => '',
	'description' => '<div align="justify">
-PTI<br />
<br />
Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br />
<br />
The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br />
<br />
&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br />
<br />
The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br />
<br />
Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br />
<br />
BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br />
<br />
Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br />
<br />
JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br />
<br />
JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.
</div>
<div align="justify">
&nbsp;
</div>
<div align="justify">
<em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx</a> </em><br />
</div>',
	'credit_writer' => 'The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 29,
	'tag_keyword' => '',
	'seo_url' => 'india039s-first-japanese-encephalitis-vaccine-launched-17117',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 17117,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 16989
$metaTitle = 'Health | India&#039;s first Japanese encephalitis vaccine launched'
$metaKeywords = 'Encephalitis,Health'
$metaDesc = '
-PTI

Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.

The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses...'
$disp = '<div align="justify">-PTI<br /><br />Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease.<br /><br />The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here.<br /><br />&quot;The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults,&quot; she said.<br /><br />The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said.<br /><br />Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said.<br /><br />BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said.<br /><br />Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI).<br /><br />JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease.<br /><br />JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.</div><div align="justify">&nbsp;</div><div align="justify"><em>The Hindustan Times, 13 September, 2012, <a href="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx" title="http://www.hindustantimes.com/India-news/Hyderabad/India-s-first-Japanese-encephalitis-vaccine-launched/Article1-929430.aspx">http://www.hindustantimes.com/India-news/Hyderabad/India-s<br />-first-Japanese-encephalitis-vaccine-launched/Article1-929<br />430.aspx</a> </em><br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

India's first Japanese encephalitis vaccine launched

-PTI Pharma firm Biological E Limited (BEL) today launched the country's first indigenous vaccine to tackle Japanese encephalitis (JE), a deadly viral disease. The vaccine, JEEV, is priced at Rs. 985. This is a one-time vaccine to be taken in two doses and will soon be available in the domestic market, Mahima Datla, senior vice-president of the city-based company, said at the launch here. "The vaccine, which will also be exported, has good safety profile and proven efficacy in Indian subjects. It is available to doctors for the prevention of JE in children and adults," she said. The technology for the vaccine has been obtained from the Austrian firm Intercell. Earlier, the vaccine was targeted to provide protection to travellers from Europe, Australia and the United States (US) among others, to regions where JE was prevalent, Datla said. Now the technology has been localised and developed as an inactivated vaccine targeting both children and adults in India, she said. BEL has a capacity to produce over ten million doses of JEEV and depending upon the demand, it will step up the output. The company has invested close to Rs. 400 crore in the development of various vaccines, Datla said. Currently, a live anti-JE vaccine is imported from China. However, the live vaccine has safety issues compared to the inactivated one, the BEL executive said, adding that JEEV has been licenced by the Drug Controller General of India (DCGI). JE is an inflammation of the brain tissue and is caused due to the infection by a mosquito bite which carries the virus. At present, there is no anti-viral therapy and the vaccination is considered the most effective way to control the disease. JE is highly prevalent in south-east Asia and the Far East and nearly 67,900 cases are recorded annually with 1169 deaths reported from India alone. During the last few years, over 10 million children have been affected worldwide by JE and 4 million have died or become permanently disabled, Datla said.   The Hindustan Times, 13 September, 2012, http://www.hindustantimes.com/India-news/Hyderabad/India-s -first-Japanese-encephalitis-vaccine-launched/Article1-929 430.aspx